よむ、つかう、まなぶ。
【参考資料6】抗微生物薬適正使用の手引き 第三版 補遺 (32 ページ)
出典
| 公開元URL | https://www.mhlw.go.jp/stf/newpage_45318.html |
| 出典情報 | 厚生科学審議会 感染症部会 薬剤耐性（AMR）に関する小委員会 抗微生物薬適正使用（AMS）等に関する作業部会（第6回 11／19）《厚生労働省》 |
ページ画像
ダウンロードした画像を利用する際は「出典情報」を明記してください。
低解像度画像をダウンロード
プレーンテキスト
資料テキストはコンピュータによる自動処理で生成されており、完全に資料と一致しない場合があります。
テキストをコピーしてご利用いただく際は資料と付け合わせてご確認ください。
14. Mermel LA, Allon M, Bouza E. et al. Clinical practice guidelines for the diagnosis and
management of intravascular catheter-related infection: 2009 Update by the Infectious
Diseases Society of America. Clin Infect Dis. 2009 Jul;49(1):1-45.
15. Gomi H, Solomkin JS, Schlossberg D. et al. Tokyo Guidelines 2018: antimicrobial therapy for
acute cholangitis and cholecystitis. J Hepatobiliary Pancreat Sci. 2018 Jan;25(1):3-16.
16. Haal S, Wielenga MCB, Fockens P. et al. Antibiotic Therapy of 3 Days May Be Sufficient After
Biliary Drainage for Acute Cholangitis: A Systematic Review. Dig Dis Sci. 2021
Dec;66(12):4128-4139.
17. Tinusz B, Szapary L, Paladi B. et al. Short-Course Antibiotic Treatment Is Not Inferior to a
Long-Course One in Acute Cholangitis: A Systematic Review. Dig Dis Sci. 2019
Feb;64(2):307-315.
18. Sawyer RG, Claridge JA, Nathens AB. et al. Trial of short-course antimicrobial therapy for
intraabdominal infection. N Engl J Med. 2015 May;372(21):1996-2005.
19. Solomkin JS, Mazuski JE, Bradley JS. et al. Diagnosis and management of complicated
intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society
and the Infectious Diseases Society of America. Clin Infect Dis. 2010 Jan;50(2):133-164.
20. Liu C, Bayer A, Cosgrove SE. et al. Clinical practice guidelines by the infectious diseases
society of america for the treatment of methicillin-resistant Staphylococcus aureus infections
in adults and children. Clin Infect Dis. 2011 Feb;52(3):e18-55.
21. Molina J, Cisneros JM. Seven-versus 14-day course of antibiotics for the treatment of
bloodstream infections by enterobacterales: a randomized, controlled trial: authors'
response. Clin Microbiol Infect. 2022 May;28(5):739-740.
22. Molina J, Rosso-Fernandez CM, Montero-Mateos E. et al. Study protocol for a randomized
clinical trial to assess 7 versus 14-days of treatment for Pseudomonas aeruginosa
bloodstream infections (SHORTEN-2 trial). PLoS One. 2022 Dec;17(12):e0277333.
23. von Dach E, Albrich WC, Brunel AS. et al. Effect of C-Reactive Protein-Guided Antibiotic
Treatment Duration, 7-Day Treatment, or 14-Day Treatment on 30-Day Clinical Failure Rate
in Patients With Uncomplicated Gram-Negative Bacteremia: A Randomized Clinical Trial.
JAMA. 2020 Jun;323(21):2160-2169.
24. Yahav D, Franceschini E, Koppel F. et al. Seven Versus 14 Days of Antibiotic Therapy for
Uncomplicated Gram-negative Bacteremia: A Noninferiority Randomized Controlled Trial.
Clin Infect Dis. 2019 Sep;69(7):1091-1098.
25. Babich T, Naucler P, Valik JK. et al. Duration of Treatment for Pseudomonas aeruginosa
Bacteremia: a Retrospective Study. Infect Dis Ther. 2022 Aug;11(4):1505-1519.
26. Bae M, Jeong Y, Bae S. et al. Short versus prolonged courses of antimicrobial therapy for
patients with uncomplicated Pseudomonas aeruginosa bloodstream infection: a retrospective
study. J Antimicrob Chemother. 2021 Dec;77(1):223-228.
27. Fabre V, Amoah J, Cosgrove SE, Tamma PD. Antibiotic Therapy for Pseudomonas
aeruginosa Bloodstream Infections: How Long Is Long Enough? Clin Infect Dis. 2019
Nov;69(11):2011-2014.
28. Turjeman A, von Dach E, Molina J. et al. Duration of antibiotic treatment for Gram-negative
bacteremia - Systematic review and individual participant data (IPD) meta-analysis.
EClinicalMedicine. 2023;55 Dec:55:101750.
32
management of intravascular catheter-related infection: 2009 Update by the Infectious
Diseases Society of America. Clin Infect Dis. 2009 Jul;49(1):1-45.
15. Gomi H, Solomkin JS, Schlossberg D. et al. Tokyo Guidelines 2018: antimicrobial therapy for
acute cholangitis and cholecystitis. J Hepatobiliary Pancreat Sci. 2018 Jan;25(1):3-16.
16. Haal S, Wielenga MCB, Fockens P. et al. Antibiotic Therapy of 3 Days May Be Sufficient After
Biliary Drainage for Acute Cholangitis: A Systematic Review. Dig Dis Sci. 2021
Dec;66(12):4128-4139.
17. Tinusz B, Szapary L, Paladi B. et al. Short-Course Antibiotic Treatment Is Not Inferior to a
Long-Course One in Acute Cholangitis: A Systematic Review. Dig Dis Sci. 2019
Feb;64(2):307-315.
18. Sawyer RG, Claridge JA, Nathens AB. et al. Trial of short-course antimicrobial therapy for
intraabdominal infection. N Engl J Med. 2015 May;372(21):1996-2005.
19. Solomkin JS, Mazuski JE, Bradley JS. et al. Diagnosis and management of complicated
intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society
and the Infectious Diseases Society of America. Clin Infect Dis. 2010 Jan;50(2):133-164.
20. Liu C, Bayer A, Cosgrove SE. et al. Clinical practice guidelines by the infectious diseases
society of america for the treatment of methicillin-resistant Staphylococcus aureus infections
in adults and children. Clin Infect Dis. 2011 Feb;52(3):e18-55.
21. Molina J, Cisneros JM. Seven-versus 14-day course of antibiotics for the treatment of
bloodstream infections by enterobacterales: a randomized, controlled trial: authors'
response. Clin Microbiol Infect. 2022 May;28(5):739-740.
22. Molina J, Rosso-Fernandez CM, Montero-Mateos E. et al. Study protocol for a randomized
clinical trial to assess 7 versus 14-days of treatment for Pseudomonas aeruginosa
bloodstream infections (SHORTEN-2 trial). PLoS One. 2022 Dec;17(12):e0277333.
23. von Dach E, Albrich WC, Brunel AS. et al. Effect of C-Reactive Protein-Guided Antibiotic
Treatment Duration, 7-Day Treatment, or 14-Day Treatment on 30-Day Clinical Failure Rate
in Patients With Uncomplicated Gram-Negative Bacteremia: A Randomized Clinical Trial.
JAMA. 2020 Jun;323(21):2160-2169.
24. Yahav D, Franceschini E, Koppel F. et al. Seven Versus 14 Days of Antibiotic Therapy for
Uncomplicated Gram-negative Bacteremia: A Noninferiority Randomized Controlled Trial.
Clin Infect Dis. 2019 Sep;69(7):1091-1098.
25. Babich T, Naucler P, Valik JK. et al. Duration of Treatment for Pseudomonas aeruginosa
Bacteremia: a Retrospective Study. Infect Dis Ther. 2022 Aug;11(4):1505-1519.
26. Bae M, Jeong Y, Bae S. et al. Short versus prolonged courses of antimicrobial therapy for
patients with uncomplicated Pseudomonas aeruginosa bloodstream infection: a retrospective
study. J Antimicrob Chemother. 2021 Dec;77(1):223-228.
27. Fabre V, Amoah J, Cosgrove SE, Tamma PD. Antibiotic Therapy for Pseudomonas
aeruginosa Bloodstream Infections: How Long Is Long Enough? Clin Infect Dis. 2019
Nov;69(11):2011-2014.
28. Turjeman A, von Dach E, Molina J. et al. Duration of antibiotic treatment for Gram-negative
bacteremia - Systematic review and individual participant data (IPD) meta-analysis.
EClinicalMedicine. 2023;55 Dec:55:101750.
32